These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32843689)

  • 1. Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium.
    Gregornik D; Salyakina D; Brown M; Roiko S; Ramos K
    Pharmacogenomics J; 2021 Feb; 21(1):8-19. PubMed ID: 32843689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics: personalizing pediatric heart transplantation.
    Van Driest SL; Webber SA
    Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pediatric perspective on genomics and prevention in the twenty-first century.
    Chaudhari BP; Manickam K; McBride KL
    Pediatr Res; 2020 Jan; 87(2):338-344. PubMed ID: 31578042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
    Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
    Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 10. Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.
    Bastaki K; Velayutham D; Irfan A; Adnan M; Mohammed S; Mbarek H; Qoronfleh MW; Jithesh PV
    Front Public Health; 2024; 12():1364221. PubMed ID: 38550311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics in Lebanon: current status, challenges and opportunities.
    Chidiac L; Yazbeck H; Mahfouz R; Zgheib NK
    Pharmacogenomics J; 2024 May; 24(3):16. PubMed ID: 38778046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG).
    Bienfait K; Chhibber A; Marshall JC; Armstrong M; Cox C; Shaw PM; Paulding C
    Hum Genet; 2022 Jun; 141(6):1165-1173. PubMed ID: 34081195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data.
    Primorac D; Bach-Rojecky L; Vađunec D; Juginović A; Žunić K; Matišić V; Skelin A; Arsov B; Boban L; Erceg D; Ivkošić IE; Molnar V; Ćatić J; Mikula I; Boban L; Primorac L; Esquivel B; Donaldson M
    Pharmacogenomics; 2020 Jan; 21(2):141-156. PubMed ID: 31950879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
    Roosan D; Hwang A; Roosan MR
    Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
    Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
    Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.